HIV Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth

HIV Drugs Market 2021 - By Type (Nucleoside Reverse Transcriptase Inhibitors (NRT’s), Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s), Protease Inhibitors, Integrase strand transfer inhibitors (INSTIs)) By Application (Hospital Pharmacies, Retail Pharmacies) By Administration (Oral, Parenteral) And By Region, Opportunities And Strategies – Global Forecast To 2030

Name: HIV Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

HIV Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth

Starting Price : $4000.00 $2800.00 | Pages : 234 | Published : May 2021 | | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

HIV Drugs Market Definition

The HIV drug market consists of sales of human immunodeficiency virus (HIV) drugs used for the treatment of HIV infection. The market consists of revenue generated by the anti-retroviral (ARV) drug companies manufacturing anti-retroviral drugs such as nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), entry and fusion inhibitors, integrase inhibitors, and protease inhibitors (PIs) for the treatment of a HIV infection.

Book your 30 minutes free consultation with our research experts

HIV Drugs Market Size

The global HIV drugs market reached a value of nearly $30,520.0 million in 2020, having increased at a compound annual growth rate (CAGR) of 8.1% since 2015. The market is expected to grow from $30,520.0 million in 2020 to $36,460.0 million in 2025 at a rate of 3.6%. The HIV drug market growth is mainly due to the growing prevalence of HIV and government initiatives which is expected to drive the demand for HIV drugs. The HIV drugs market is expected to grow from $36,460.0 million in 2025 to $40,303.1 million in 2030 at a CAGR of 2.0%.

Growth in the historic period resulted from increased government support and initiatives, rise in healthcare expenditure, increase in HIV research and development spending, increased incidence of HIV infection, rise in awareness and economic growth in emerging markets. This growth was restricted by challenges due to regulatory changes, patent expiration of drugs, rise in alternative medications and low healthcare access.

Going forward, government initiatives, cheaper interest rates, development in drug discovery and cheaper interest rates will support the market growth. Side effects of HIV drugs, shortage of supply of HIV drugs, impact of COVID-19 and low rate of voluntary screening are major factors that could hinder the growth of the HIV drugs market in the future.

HIV Drugs Market Drivers

The key drivers of the HIV drugs market include:

Government Initiatives

Government initiatives and efforts towards implementing reforms have had a significant impact on the market, in both developed and developing countries. For instance, the Health Resources and Services Administration’s (HRSA) Bureau of Primary Health Care announced the availability of around $83 million for up to 300 health centers for the fiscal year 2021 Ending the HIV Epidemic- Primary Care HIV Prevention (PCHP) program. The PCHP funding is likely to expand HIV prevention services with the motive of decreasing the risk of HIV transmission across 57 geographic locations recognized by Ending the HIV Epidemic: A Plan for America. Additionally, in December 2020, the fiscal year budget passed included $386 million for the implementation of the EHE initiative along with $175 million for the Centers for Disease Control and Prevention (CDC) to reduce new HIV infections. Therefore, these government initiatives push the development of HIV drug demand and thereby contributing to the growth of the market in the forecast period.

HIV Drugs Market Restraints

The key restraints on the HIV drugs market include:

Coronavirus Pandemic

The outbreak of Coronavirus disease (COVID-19) has acted as a significant restraint on the HIV drug market in 2020 as supply chains were disrupted due to restrictions on the trade of pharmaceutical ingredients and products across countries. COVID-19 is an infectious disease with flu-like symptoms including fever, cough, and difficulty in breathing. The virus was first identified in 2019 in Wuhan, Hubei province of the People’s Republic of China, and spread globally including Western Europe, North America, and Asia. Various steps taken by national governments to contain the spread of virus have resulted in a decline in economic activity with countries entering a state of 'lockdown' and the outbreak is expected to continue to hinder businesses throughout 2020 and into 2021. Pharmaceutical markets such as this one has been relatively less impacted however due to the continued availability of drugs during government lockdowns and inelasticity of demand. It is expected that the HIV drugs market will recover from the shock across the forecast period as it is a 'black swan' event and not related to ongoing or fundamental weaknesses in the market or the global economy.

HIV Drugs Market Trends

Major trends influencing the HIV drugs market include:

Multi-Class Combination Products For HIV Treatment

Companies operating in the HIV drugs market are increasingly focusing on the development and launch of multi-class combination for treatment of retroviral infections. Combination drugs combine multiple medications into one drug form. Multi-class combination drugs or single-tablet regimens (STRs), include both NRTIs and NNRTIs: doravirine, lamivudine, and tenofovir disoproxil fumarate (Delstrigo). Multi-class combination products are gaining significant popularity attributing to rising burden of HIV. For instance, in December 2019, Hetero, an India-based pharmaceutical company launched an anti-retroviral combination drug consisting a combination of drugs including Bictegravir (50mg), Emtricitabine (200mg), and Tenofovir Alafenamide (25mg) for treating patients with HIV.

3D Bioprinting Technology

HIV drug manufacturing companies are increasingly adopting 3D bioprinting technology in the development and manufacturing processes of HIV drugs to reduce manufacturing costs and increase production efficiencies and expedite the process of drug discovery. 3D bioprinting is a manufacturing process where a 3D structure of the tissue is created using bio-ink. Bio-inks are materials which are used to produce artiificial live tissues using 3D printing. For instance, Viiv Healthcare Limited, a USA-based pharmaceutical company specializing in developing HIV therapies is using HP's D300 for creating latency reversal drugs for HIV. Moreover, companies are continuously manufacturing 3D bioprinters for overcoming technical limitations plaguing pharmaceutical research, regenerative medicine, and tissue engineering. For example, in December 2020, mimiX Biotherapeutics, a biotechnology company launched cymatiX, the company’s first acoustic bioprinter intended for an affordable and fast method of fabricating multi-cellular tissue constructs.

Opportunities And Recommendations In The HIV Drugs Market

Opportunities – The top opportunities in the HIV drugs market segmented by type will arise in the non-nucleoside reverse transcriptase inhibitors segment, which will gain $6,152 million of global annual sales by 2025. The top opportunities in the HIV drugs market segmented by route of administration will arise in the oral segment, which will gain $5,692.8 million of global annual sales by 2025. The top opportunities in the HIV drugs market segmented by application will arise in the hospital pharmacies segment, which will gain $3,175.7 million of global annual sales by 2025. The HIV drugs’ market size will gain the most in the USA at $2,466 million. Market-trend-based strategies for the HIV drugs market include investing in 3D bioprinting technology, new product innovations, developing multi-class combination products for HIV treatment and investing in strategic collaborations and agreements. Player-adopted strategies in the HIV drugs market include investing in expanding operations through innovative product launches, investing in collaborations and mergers and getting approvals for new drugs for HIV treatment.

Recommendations – To take advantage of the opportunities, The Business Research Company recommends the HIV drug companies to focus on the use of automation, focus on combination therapy, focus on research and development of innovative products, focus on collaborations, expand in markets with high incidence of HIV, provide competitively priced offerings, premium pricing for innovative drugs, companies should focus on increasing awareness on HIV infection, companies should leverage e-commerce tools to maximize reach, focus on uneducated population and target young population.

HIV Drugs Market Segmentation

The HIV drugs market is segmented by type, by application, by administration and by geography.
By Type -
The HIV drugs market is segmented by type into

a) Nucleoside Reverse Transcriptase Inhibitors (NRT’s)
b) Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s)
c) Protease Inhibitors
d) Integrase strand transfer inhibitors (INSTIs)
e) Others

The non-nucleoside reverse transcriptase inhibitors were the largest segment of the HIV drugs market by type, accounting for 29.4% of the total market in 2020. Going forward, it is also is expected to be the fastest growing segment in the HIV drugs market, at a CAGR of 11.1% during 2020-2025.
By Application-
The HIV drugs market is further segmented by application into

a) Hospital Pharmacies
b) Retail Pharmacies
c) Others

The hospital pharmacy was the largest segment of the HIV drugs market by application, accounting for 64.6% of the total market in 2020. Going forward, the others segment is expected to be the fastest growing segment in the HIV drugs market, at a CAGR of 5.4%, during 2020-2025.
By Administration-
The HIV drugs market is further segmented by administration into

a) Oral
b) Parenteral

The oral was the largest segment of the HIV drugs market by route of administration, accounting for 94.5% of the total market in 2020. Going forward, it is also expected to the fastest growing segment in the HIV drugs market, at a CAGR of 3.7%.
By Geography
The industrial machinery market is segmented by geography into

o North America
- • USA

• UK
• Germany
• France

• China
• Japan
• India
• Australia
• Indonesia
• South Korea

• Russia

• Brazil

North America was the largest region in the global HIV drugs market, accounting for 51.1% of the total in 2020. It was followed by the Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the HIV drugs market will be Africa and Asia-Pacific, where growth will be at CAGRs of 6.0% and 4.1% respectively. These will be followed by Middle East and North America, where the markets are expected to register CAGRs of 4.9% and 3.5% respectively.

HIV Drugs Competitive Landscape

Major Competitors In The HIV Drugs Market are:

Gilead Sciences, Inc

GlaxoSmithKline plc.

Johnson & Johnson

Merck & Co., Inc.

Boehringer Ingelheim International GmbH

Other Competitors In The HIV Drugs Market Include:

Cipla

Aurobindo Pharma

AbbVie

Aspen Pharmacare Limited

Pharmacare Ltd.

Zion Medical

Pfizer

Abbott Laboratories

Alfa Rio Química Ltda.

Globe Quimica S/A

Nortec Química S.A.

Microbiológica Química e Farmacêutica

Indústria e Comércio de Medicamentos Labogen S.A.

AstraZeneca

Gritstone Oncology

Enzolytics Inc.

BioClonetics Immunotherapeutics, Inc.

Dewpoint Therapeutics

ViiV Healthcare

Lyndra Therapeutics

Mylan N.V.

Bristol-Myers Squibb Company

F. Hoffmann-La Roche AG

Teva Canada

Pharmstandard

Pharmasyntez

R-Pharm

Alium

ChemRar Group

CytoDyn?Inc.

Janssen Pharmaceutical

Bavarian Nordic

Emcure Pharmaceuticals

Micro Labs Limited

Shanghai Desano Bio Pharmaceutical

Northeast Pharmaceutical Group Co. Ltd

Dr. Reddy's Laboratories Ltd.

Sun Pharmaceutical Industries Ltd

Strides Arcolab Limited

Hetero labs limited

1. HIV Drugs Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

7. Segmentation By Geography

7.1 Segmentation By Type

7.2 Segmentation By Application

7.3 Segmentation By Administration

8. HIV Drugs Market Characteristics

8.1 Market Definition

8.2 Market Segmentation By Type

8.2.1 Nucleoside Reverse Transcriptase Inhibitors (NRT’s)

8.2.2 Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s)

8.2.3 Protease Inhibitors

8.2.4 Integrase strand transfer inhibitors (INSTIs)

8.2.5 Others

8.3 Market Segmentation By Application

8.3.1 Hospital Pharmacies

8.3.2 Retail Pharmacies

8.3.3 Others

8.4 Market Segmentation By Administration

8.4.1 Oral

8.4.2 Parenteral

9 HIV Drugs Market Trends And Strategies

9.1 Multi-Class Combination Products For HIV Treatment

9.2 3D Bioprinting Technology

9.3 Increasing Number Of Pipeline Studies And Drug Development

9.4 Global Research Initiatives And Funding

9.5 New Product Innovations

9.6 Strategic Collaborations And Agreements

10 Impact Of COVID-19 On The HIV Drugs Market

10.1 Consumer Perception

10.2 High Mortality Among HIV/AIDS Patients

10.3 COVID-19 Impact On HIV Treatment

10.4 High Demand for HIV And Anti-viral Drugs During COVID-19 Outbreak

10.5 Conclusion

11 Global HIV Drugs Market Size And Growth

11.1 Market Size

11.2 Historic Market Growth, 2015 – 2020, Value ($ Million)

11.2.1 Drivers Of The Market 2015 – 2020

11.2.2 Restraints On The Market 2015 – 2020

11.3 Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

11.3.1 Drivers Of The Market 2020 – 2025

11.3.2 Restraints On The Market 2020 – 2025

12 Global HIV Drugs Market Segmentation

12.1 Global HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

12.1.1 Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

12.1.2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

12.1.3 Integrase Strand Transfer Inhibitors (INSTIs)

12.1.4 Protease Inhibitors (PIs)

12.1.5 Others

12.2 Global HIV Drugs Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

12.2.1 Hospital Pharmacies

12.2.2 Retail Pharmacies

12.2.3 Others

12.3 Global HIV Drugs Market, Segmentation By Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

12.3.1 Oral

12.3.2 Parenteral

13 HIV Drugs Market, Regional And Country Analysis

13.1 Global HIV Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

13.2 Global HIV Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14 Asia-Pacific HIV Drugs Market

14.1 Asia-Pacific HIV Drugs Market Overview

14.1.1 Region Information

14.1.2 Market Information

14.1.3 COVID-19 Impact

14.1.4 Background Information

14.1.5 Government Initiatives

14.1.6 Regulations

14.1.7 Regulatory Bodies

14.1.8 Major Associations

14.1.9 Taxes levied

14.1.10 Corporate Tax Structure

14.1.11 Investments

14.1.12 Major Companies

14.2 Asia-Pacific HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

14.3 Asia-Pacific HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

14.4 Asia-Pacific HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.5 Asia-Pacific HIV Drugs Market: Country Analysis

14.6 China HIV Drugs Market

14.7 China HIV Drugs Market Overview

14.7.1 Country Information

14.7.2 Market Information

14.7.3 COVID-19 Impact

14.7.4 Background Information

14.7.5 Government Initiatives

14.7.6 Regulations

14.7.7 Regulatory Bodies

14.7.8 Major Associations

14.7.9 Taxes levied

14.7.10 Corporate Tax Structure

14.7.11 Investments

14.7.12 Major Companies

14.8 China HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

14.9 China HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

14.10 China HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.11 India HIV Drugs Market

14.12 India HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

14.13 India HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

14.14 India HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.15 Japan HIV Drugs Market

14.16 Japan HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

14.17 Japan HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

14.18 Japan HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.19 Australia HIV Drugs Market

14.20 Australia HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

14.21 Australia HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

14.22 Australia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.23 Indonesia HIV Drugs Market

14.24 Indonesia HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

14.25 Indonesia HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

14.26 Indonesia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

14.27 South Korea HIV Drugs Market

14.28 South Korea HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

14.29 South Korea HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

14.30 South Korea HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

15 Western Europe HIV Drugs Market

15.1 Western Europe HIV Drugs Market Overview

15.1.1 Region Information

15.1.2 Market Information

15.1.3 COVID-19 Impact

15.1.4 Background Information

15.1.5 Government Initiatives

15.1.6 Regulations

15.1.7 Regulatory Bodies

15.1.8 Major Associations

15.1.9 Taxes levied

15.1.10 Corporate Tax Structure

15.1.11 Investments

15.1.12 Major Companies

15.2 Western Europe HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

15.3 Western Europe HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

15.4 Western Europe HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

15.5 Western Europe HIV Drugs Market: Country Analysis

15.6 UK HIV Drugs Market

15.7 UK HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

15.8 UK HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

15.9 UK HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

15.10 Germany HIV Drugs Market

15.11 Germany HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

15.12 Germany HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

15.13 Germany HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

15.14 France HIV Drugs Market

15.15 France HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

15.16 France HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

15.17 France HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

16 Eastern Europe HIV Drugs Market

16.1 Eastern Europe HIV Drugs Market Overview

16.1.1 Region Information

16.1.2 Market Information

16.1.3 COVID-19 Impact

16.1.4 Background Information

16.1.5 Government Initiatives

16.1.6 Regulations

16.1.7 Regulatory Bodies

16.1.8 Tax Levied

16.1.9 Major Associations

16.1.10 Corporate Tax Structure

16.1.11 Investments

16.1.12 Major Companies

16.2 Eastern Europe HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

16.3 Eastern Europe HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

16.4 Eastern Europe HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

16.5 Eastern Europe HIV Drugs Market: Country Analysis

16.6 Russia HIV Drugs Market

16.7 Russia HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

16.8 Russia HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

16.9 Russia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

17 North America HIV Drugs Market

17.1 North America HIV Drugs Market Overview

17.1.1 Region Information

17.1.2 Market Information

17.1.3 COVID-19 Impact

17.1.4 Background Information

17.1.5 Government Initiatives

17.1.6 Regulations

17.1.7 Regulatory Bodies

17.1.8 Major Associations

17.1.9 Taxes levied

17.1.10 Corporate Tax Structure

17.1.11 Investments

17.1.12 Major Companies

17.2 North America HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

17.3 North America HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

17.4 North America HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

17.5 North America HIV Drugs Market: Country Analysis

17.6 USA HIV Drugs Market

17.6.1 USA HIV Drugs Market Overview

17.6.2 Country Information

17.6.3 Market Information

17.6.4 COVID-19 Impact

17.6.5 Background Information

17.6.6 Government Initiatives

17.6.7 Regulations

17.6.8 Regulatory Bodies

17.6.9 Major Associations

17.6.10 Corporate Tax Structure

17.6.11 Investments

17.6.12 Major Companies

17.7 USA HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

17.8 USA HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

17.9 USA HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

18 South America HIV Drugs Market

18.1 South America HIV Drugs Market Overview

18.1.1 Region Information

18.1.2 Market Information

18.1.3 COVID-19 Impact

18.1.4 Background Information

18.1.5 Government Initiatives

18.1.6 Regulations

18.1.7 Regulatory Bodies

18.1.8 Tax Levied

18.1.9 Major Associations

18.1.10 Corporate Tax Structure

18.1.11 Investments

18.1.12 Major Companies

18.2 South America HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

18.3 South America HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

18.4 South America HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

18.5 South America HIV Drugs Market: Country Analysis

18.6 Brazil HIV Drugs Market

18.7 Brazil HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

18.8 Brazil HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

18.9 Brazil HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

19 Middle East HIV Drugs Market

19.1 Middle East HIV Drugs Market Overview

19.1.1 Region Information

19.1.2 Market Information

19.1.3 COVID-19 Impact

19.1.4 Background Information

19.1.5 Government Initiatives

19.1.6 Regulations

19.1.7 Regulatory Bodies

19.1.8 Major Associations

19.1.9 Taxes Levied

19.1.10 Corporate Tax Structure

19.1.11 Investment

19.1.12 Major Companies

19.2 Middle East HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

19.3 Middle East HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

19.4 Middle East HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

20 Africa HIV Drugs Market

20.1 Africa HIV Drugs Market Overview

20.1.1 Region Information

20.1.2 Market Information

20.1.3 COVID-19 Impact

20.1.4 Background Information

20.1.5 Government Initiatives

20.1.6 Regulations

20.1.7 Regulatory Bodies

20.1.8 Major Associations

20.1.9 Taxes Levied

20.1.10 Corporate Tax Structure

20.1.11 Investments

20.1.12 Major Companies

20.2 Africa HIV Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

20.3 Africa HIV Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

20.4 Africa HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

21 Global HIV Drugs Market Competitive Landscape

21.1 Company Profiles

21.2 Gilead Sciences, Inc.

21.2.1 Company Overview

21.2.2 Products And Services

21.2.3 Business Strategy

21.2.4 Financial Overview

21.3 GlaxoSmithKline

21.3.1 Company Overview

21.3.2 Products And Services

21.3.3 Business Strategy

21.3.4 Financial Overview

21.4 Johnson & Johnson

21.4.1 Company Overview

21.4.2 Products And Services

21.4.3 Business Strategy

21.4.4 Financial Overview

21.5 Merck & Co., Inc.

21.5.1 Company Overview

21.5.2 Products And Services

21.5.3 Business Strategy

21.5.4 Financial Overview

21.6 Boehringer Ingelheim International GmbH

21.6.1 Company Overview

21.6.2 Products And Services

21.6.3 Financial Overview

22 Key Mergers And Acquisitions In The HIV Drugs Market

22.1 Gilead Sciences Partnered With Gritstone Oncology

22.2 Beximco Pharmaceuticals Acquired Stakes in Sanofi Bangladesh

22.3 CytoDyn Inc. Collaborates With amfAR

22.4 Merck Partnered With Dewpoint Therapeutics

22.5 ViiV Healthcare Collaborated With Chapel Hill

22.6 HOOKIPA Pharma Inc. Partners With Gilead Sciences

22.7 Lyndra Therapeutics Collaborates With Gilead Sciences

22.8 Mylan Acquired Ascendis Health

22.9 Mylan Collaborate With Atomo Diagnostics

22.10 ViiV Healthcare To Collaborate With Janssen

23 HIV Drugs Market Opportunities And Strategies

23.1 Global HIV Drugs Market In 2025 – Countries Offering Most New Opportunities

23.2 Global HIV Drugs Market In 2025 – Segments Offering Most New Opportunities

23.3 Global HIV Drugs Market In 2025 – Growth Strategies

23.3.1 Market Trend Based Strategies

23.3.2 Competitor Strategies

24 HIV Drugs Market Conclusions And Recommendations

24.1 Conclusions

24.2 Recommendations

24.2.1 Product

24.2.2 Place

24.2.3 Price

24.2.4 Promotion

24.2.5 People

25 Appendix

25.1.1 Market Data Sources

25.1.2 Research Methodology

25.1.3 Currencies

25.1.4 Research Inquiries

25.1.5 The Business Research Company

25.1.6 Copyright and Disclaimer

List Of Tables

Table 1: Global HIV Drugs Market, Historic, 2015 – 2020, $ Million

Table 2: Global HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 3: Global HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 4: Global HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 5: Global HIV Drugs Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 6: Global HIV Drugs Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 7: Global HIV Drugs Market, Segmentation By Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 8: Global HIV Drugs Market, Segmentation By Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 9: Global HIV Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Table 10: Global HIV Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 11: Global HIV Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Table 12: Global HIV Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 13: Asia Pacific Population By Age Group, 2015-2025, Thousands

Table 14: Asia-Pacific Per Capita Healthcare Expenditure, 2015-2019, $

Table 15: Asia Pacific GDP Per Capita, 2015-2019, $

Table 16: Asia Pacific HIV Disease Prevalence, 2015-2019, Number Of Patients

Table 17: Asia-Pacific HIV Drugs Market, Historic, 2015 – 2020, $ Million

Table 18: Asia-Pacific HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 19: Asia-Pacific HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 20: Asia-Pacific HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 21: China Population By Age Group, 2015-2025, Thousands

Table 22: China Per Capita Healthcare Expenditure, 2015-2019, $

Table 23: China GDP Per Capita, 2015-2019, $

Table 24: China HIV Disease Prevalence, 2015-2019, Number Of Patients

Table 25: China HIV Drugs Market, Historic, 2015 – 2020, $ Million

Table 26: China HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 27: China HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 28: China HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 29: India HIV Drugs Market, Historic, 2015 – 2020, $ Million

Table 30: India HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 31: India HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 32: India HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 33: Japan HIV Drugs Market, Historic, 2015 – 2020, $ Million

Table 34: Japan HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 35: Japan HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 36: Japan HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 37: Australia HIV Drugs Market, Historic, 2015 – 2020, $ Million

Table 38: Australia HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 39: Australia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 40: Australia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 41: Indonesia HIV Drugs Market, Historic, 2015 – 2020, $ Million

Table 42: Indonesia HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 43: Indonesia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 44: Indonesia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 45: South Korea HIV Drugs Market, Historic, 2015 – 2020, $ Million

Table 46: South Korea HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 47: South Korea HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 48: South Korea HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 49: Western Europe Population By Age Group, 2015-2025, Thousands

Table 50: Western Europe Per Capita Healthcare Expenditure, 2015-2019, $

Table 51: Western Europe GDP Per Capita, 2015-2019, $

Table 52: Western Europe HIV Disease Prevalence, 2015-2019, Number Of Patients

Table 53: Western Europe HIV Drugs Market, Historic, 2015 – 2020, $ Million

Table 54: Western Europe HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 55: Western Europe HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 56: Western Europe HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 57: UK HIV Drugs Market, Historic, 2015 – 2020, $ Million

Table 58: UK HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 59: UK HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 60: UK HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 61: Germany HIV Drugs Market, Historic, 2015 – 2020, $ Million

Table 62: Germany HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 63: Germany HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 64: Germany HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 65: France HIV Drugs Market, Historic, 2015 – 2020, $ Million

Table 66: France HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 67: France HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 68: France HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 69: Eastern Europe Population By Age Group, 2015-2025, Thousands

Table 70: Eastern Europe Per Capita Healthcare Expenditure, 2015-2019, $

Table 71: Eastern Europe GDP Per Capita, 2015-2019, $

Table 72: Eastern Europe HIV Disease Prevalence, 2015-2019, Number Of Patients

Table 73: Eastern Europe HIV Drugs Market, Historic, 2015 – 2020, $ Million

Table 74: Eastern Europe HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 75: Eastern Europe HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 76: Eastern Europe HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 77: Russia HIV Drugs Market, Historic, 2015 – 2020, $ Million

Table 78: Russia HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 79: Russia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 80: Russia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 81: North America Population By Age Group, 2015-2025, Thousands

Table 82: North America Per Capita Healthcare Expenditure, 2015-2019, $

Table 83: North America GDP Per Capita, 2015-2019, $

Table 84: North America HIV Disease Prevalence, 2015-2019, Number Of Patients

Table 85: North America HIV Drugs Market, Historic, 2015 – 2020, $ Million

Table 86: North America HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 87: North America HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 88: North America HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 89: USA Population By Age Group, 2015-2025, Thousands

Table 90: USA Per Capita Healthcare Expenditure, 2015-2019, $

Table 91: USA GDP Per Capita, 2015-2019, $

Table 92: USA HIV Disease Prevalence, 2015-2019, Number Of Patients

Table 93: USA HIV Drugs Market, Historic, 2015 – 2020, $ Million

Table 94: USA HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 95: USA HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 96: USA HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 97: South America Population By Age Group, 2015-2025, Thousands

Table 98: South America Per Capita Healthcare Expenditure, 2015-2019, $

Table 99: South America GDP Per Capita, 2015-2019, $

Table 100: South America HIV Disease Prevalence, 2015-2019, Number Of Patients

Table 101: South America HIV Drugs Market, Historic, 2015 – 2020, $ Million

Table 102: South America HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 103: South America HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 104: South America HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 105: Brazil HIV Drugs Market, Historic, 2015 – 2020, $ Million

Table 106: Brazil HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 107: Brazil HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 108: Brazil HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 109: Middle East Population By Age Group, 2015-2025, Thousands

Table 110: Middle East Per Capita Healthcare Expenditure, 2015-2019, $

Table 111: Middle East GDP Per Capita, 2015-2019, $

Table 112: Middle East HIV Disease Prevalence, 2015-2019, Number Of Patients

Table 113: Middle East HIV Drugs Market, Historic, 2015 – 2020, $ Million

Table 114: Middle East HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 115: Middle East HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 116: Middle East HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 117: Africa Population By Age Group, 2015-2025, Thousands

Table 118: Africa Per Capita Healthcare Expenditure, 2015-2019, $

Table 119: Africa GDP Per Capita, 2015-2019, $

Table 120: Africa HIV Disease Prevalence, 2015-2019, Number Of Patients

Table 121: Africa HIV Drugs Market, Historic, 2015 – 2020, $ Million

Table 122: Africa HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Table 123: Africa HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Table 124: Africa HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

Table 125: Global HIV Drugs Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)

Table 126: Gilead Sciences, Inc. – Financial Performance, 2015 – 2019, $ Billion

Table 127: GlaxoSmithKline Plc. – Financial Performance, 2015 – 2019, $ Billion

Table 128: Johnson & Johnson (J&J) – Financial Performance, 2015 – 2019, $ Billion

Table 129: Merck & Co. – Financial Performance, 2015-2019, $ Billion

Table 130: Boehringer Ingelheim GmbH – Financial Performance, 2015 - 2019, $ Billion

Table 131: Global HIV Drugs Market Size Gain ($ Million), 2020 – 2025, By Country

Table 132: Global HIV Drugs Market Size Gain ($ Million), Segmentation By Type, 2020 – 2025

Table 133: Global HIV Drugs Market Size Gain ($ Million), Segmentation By Application, 2020 – 2025

Table 134: Global HIV Drugs Market Size Gain ($ Million), Segmentation By Administration, 2020 – 2025

Table 135: HIV Drugs - Market Data Sources

List Of Figures

Figure 1: Global HIV Drugs Market Segmentation By Type

Figure 2: Global HIV Drugs Market Segmentation By Application

Figure 3: Global HIV Drugs Market Segmentation By Administration

Figure 4: Global HIV Drugs Market, Historic, 2015 – 2020, $ Million

Figure 5: Global HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 6: Global HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 7: Global HIV Drugs Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 8: Global HIV Drugs Market, Segmentation By Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 9: Global HIV Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 10: Global HIV Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 11: Asia-Pacific HIV Drugs Market, Historic, 2015 – 2020, $ Million

Figure 12: Asia-Pacific HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 13: Asia-Pacific HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 14: China HIV Drugs Market, Historic, 2015 – 2020, $ Million

Figure 15: China HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 16: China HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 17: India HIV Drugs Market, Historic, 2015 – 2020, $ Million

Figure 18: India HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 19: India HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 20: Japan HIV Drugs Market, Historic, 2015 – 2020, $ Million

Figure 21: Japan HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 22: Japan HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 23: Australia HIV Drugs Market, Historic, 2015 – 2020, $ Million

Figure 24: Australia HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 25: Australia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 26: Indonesia HIV Drugs Market, Historic, 2015 – 2020, $ Million

Figure 27: Indonesia HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 28: Indonesia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 29: South Korea HIV Drugs Market, Historic, 2015 – 2020, $ Million

Figure 30: South Korea HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 31: South Korea HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 32: Western Europe HIV Drugs Market, Historic, 2015 – 2020, $ Million

Figure 33: Western Europe HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 34: Western Europe HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 35: UK HIV Drugs Market, Historic, 2015 – 2020, $ Million

Figure 36: UK HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 37: UK HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 38: Germany HIV Drugs Market, Historic, 2015 – 2020, $ Million

Figure 39: Germany HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 40: Germany HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 41: France HIV Drugs Market, Historic, 2015 – 2020, $ Million

Figure 42: France HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 43: France HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 44: Eastern Europe HIV Drugs Market, Historic, 2015 – 2020, $ Million

Figure 45: Eastern Europe HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 46: Eastern Europe HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 47: Russia HIV Drugs Market, Historic, 2015 – 2020, $ Million

Figure 48: Russia HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 49: Russia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 50: North America HIV Drugs Market, Historic, 2015 – 2020, $ Million

Figure 51: North America HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 52: North America HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 53: USA HIV Drugs Market, Historic, 2015 – 2020, $ Million

Figure 54: USA HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 55: USA HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 56: South America HIV Drugs Market, Historic, 2015 – 2020, $ Million

Figure 57: South America HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 58: South America HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 59: Brazil HIV Drugs Market, Historic, 2015 – 2020, $ Million

Figure 60: Brazil HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 61: Brazil HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 62: Middle East HIV Drugs Market, Historic, 2015 – 2020, $ Million

Figure 63: Middle East HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 64: Middle East HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 65: Africa HIV Drugs Market, Historic, 2015 – 2020, $ Million

Figure 66: Africa HIV Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 67: Africa HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 68: Global HIV Drugs Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)

Figure 69: Gilead Sciences, Inc. – Financial Performance, 2015 – 2019, $ Billion

Figure 70: GlaxoSmithKline Plc. – Financial Performance, 2015 – 2019, $ Billion

Figure 71: Johnson & Johnson (J&J) – Financial Performance, 2015 – 2019, $ Billion

Figure 72: Merck & Co. – Financial Performance, 2015-2019, $ Billion

Figure 73: Boehringer Ingelheim GmbH – Financial Performance, 2015 - 2019, $ Billion

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

What Is The Compression Therapy Market Overview In 2022?

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the nucleic acid based gene therapy market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the radiopharmaceuticals market research report 2022 with industry size, share, segments and market growth

Drugs For Erectile Dysfunction Global Market Report 2024 – By Drugs (Sildenafil Citrate, Mirodenafil , Vardenafil), By Mode of Administration (Oral, Topical, Injections), By End users (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Drugs For Hormonal Replacement Therapy Global Market Report 2024 – By Therapy Type (Estrogen Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, Menopause, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Drugs for Immunotherapy Global Market Report 2024 – By Type (Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors, Other Types), By Therapy Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Other Therapy Areas), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Analgesics Global Market Report 2024 – By Type (Non-opioids, Opioids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores), By Application (Internal Analgesics, External Analgesics) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Bladder Cancer Drugs Global Market Report 2024 – By Type (Non-Muscle-Invasive Bladder Cancer, Muscle-Invasive Bladder Cancer), By Application (Low-Grade Tumors, High-Grade Tumors), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Drugs For Benign Prostatic hypertrophy Global Market Report 2024 – By Type (Alpha Blocker, 5-alpha Reductase Inhibitor, Phosphodiesterase-5 Inhibitor, Other Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospital Pharmacies, Retail Pharmacies, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

HIV Drugs Global Market Report 2024 – By Type (Nucleoside Reverse Transcriptase Inhibitors (NRT’s), Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s), Protease Inhibitors, Integrase strand transfer inhibitors (INSTIs), Other Types), By Administration (Oral, Parenteral), By Application (Hospital Pharmacies, Retail Pharmacies, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Acne Drugs Market 2021 - By Type (Non-Inflammatory Acne Drugs, Inflammatory Acne Drugs), By End-User (Hospitals And Clinics), By Therapeutic Class (Benzoyl Peroxide, Retinoids, Antibiotics, Salicylice) And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Frequently Asked Questions

What is the definition of the hiv drugs market market?

How will the hiv drugs market market drivers and restraints affect hiv drugs market market dynamics? What forces will shape the hiv drugs market industry going forward?

The hiv drugs market growth is aided by government initiatives. However, some hiv drugs market restraints include coronavirus pandemic request a sample here

What is the forecast market size of the hiv drugs market market?

The hiv drugs market forecast is expected to reach $40,303.1 million in 2030 at a compound annual growth rate of 2%. request a sample here

How is the hiv drugs market market segmented?

The global hiv drugs market is segmented -
1) By Type: Nucleoside Reverse Transcriptase Inhibitors (NRT’s), Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s), Protease Inhibitors, Integrase strand transfer inhibitors (INSTIs), Others
2) By Application: Hospital Pharmacies, Retail Pharmacies, Others
3) By Administration: Oral, Parenteral request a sample here

Which region has largest share, and what is the market size and growth by geography according to the hiv drugs market global market report?

For this and further detailed insights on the market, request a sample here. request a sample here.

Who are the key players of the global hiv drugs market market?

Top competitors in the hiv drugs market include Gilead Sciences, Inc, GlaxoSmithKline plc., Johnson & Johnson, Merck & Co., Inc., Boehringer Ingelheim International GmbH request a sample here.

What are the key trends in the global hiv drugs market market?

Major trends influencing the hiv drugs market include multi-class combination products for hiv treatment request a sample here.

What are the major opportunities in the hiv drugs market market and the approaches companies can take to take advantage of them?

For this and further detailed insights on the market, request a sample here. request a sample here.

How does the hiv drugs market market relate to the overall economy and other similar markets?

request a sample here.

HIV Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth

HIV Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth

HIV Drugs Market Definition

HIV Drugs Market Size

HIV Drugs Market Drivers

HIV Drugs Market Restraints

HIV Drugs Market Trends

Opportunities And Recommendations In The HIV Drugs Market

HIV Drugs Market Segmentation

HIV Drugs Competitive Landscape

Major Competitors In The HIV Drugs Market are:

Other Competitors In The HIV Drugs Market Include:

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions